Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Diabetes Manag (Lond). 2011 Nov 1;1(6):589–600. doi: 10.2217/DMT.11.57

Table 1.

Point prevalence of ketosis-prone Type 2 diabetes mellitus in different studies.

Study (year) Study
Type
Population type n Age
(years)
BMI Ethnicity Point
prevalence
(%)
Ref.
Oli (1978) PCS Nonobese, newly diagnosed with DM and requiring insulin initially 43 - - Nigerian 27.9 [27]
Westphal (1996) RCR Patients with new-onset DKA 228 32.2 ± 1.3 28.6 ± 1.2 Caucasian (30%) Hispanic (36%) Native American (21%) AA (13%) 24 [32]
Pinhas-Hamiel et al. (1997) RCR ICA negative NIDDM Adolescents 70 14.0 ± 0.7 40.7 ± 1.2 AA 17 [29]
Umpierrez et al. (1997) PCS AA presenting with DKA 144 37 ± 1 32 ± 0.3 AA 29 [31]
Wilson et al. (1997) RCR Apache Indians with NIDDM who had been treated for an episode of DKA 714 40.8 ± 13.9 24.9 ± 4.4 Native American 2.3 [57]
Nagasaka et al. (1998) RCT Hospitalized T2DM patients of <30 years 6000 18–23 36.4 ± 6.8 Japanese 10.3 [28]
Umpierrez et al. (1999) RCT AA presenting with hyperglycemic crisis 131 40 ± 2 37 ± 1 AA 59 [6]
Balasubramanyam et al. (1999) CC Patients hospitalized with DKA 141 47.3 ± 13.7 30.5 ± 7.5 AA (37%) Hispanic (26%) Caucasian (6%) 39 [33]
Tan et al. (2000) RCR Outpatient diabetes clinic >3000 34.8 ± 10.6 28.6 ± 2.3 Chinese <0.3 [17]
Newton and Ruskin (2004) CC Patients hospitalized with DKA 138 35.0 ± 12.5 30.5 ± 7.5 AA (47%) Hispanic (35%) Caucasian (17%) Native American (1%) 22 [58]
Jabbar et al. (2004) RCR Patients hospitalized with DKA 57 48 ± 7 25.5 ± 6.2 Pakistani 63 [26]
Mauvais-Jarvis et al. (2004) CC Patients admitted for uncontrolled DM 233 39.1 ± 9.5 24.9 ± 4.8 French nationals of sub-Saharan African descent 50 [8]
Manrique et al. (2007) RCR Patients hospitalized with DKA 54 46 ± 14 26.7 ± 6.3 Peruvians 46 [59]
Sobngwi et al. (2008) CC All hospitalized diabetics who did not have T1DM 187 38 ± 11 27.7 ± 4.3 French nationals of sub-Saharan African descent 43 [14]

AA: African–American; CC: Case–control study; DKA: Diabetic ketoacidosis; DM: Diabetes mellitus; ICA: Islet cell antibodies; NIDDM: Noninsulin dependent diabetes mellitus; PCS: Prospective case series; RCR: Retrospective chart review; RCT: Randomized controlled trial; T1DM: Type 1 diabetes mellitus; T2DM: Type 2 diabetes mellitus.